Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/24/2003US20030077275 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences
04/24/2003US20030077267 Purified forms of DNase
04/24/2003US20030077259 Induction of beta cell differentiation in human cells
04/24/2003US20030077256 Pancreas regeneration using embryonic pancreatic cells
04/24/2003US20030077252 Vaccination against plaque forming diseases; inhibiting aggregation of amyloid in mammal and/or to cause disaggregation of amyloid; treating brain disorder, Alzheimer's disease
04/24/2003US20030077251 Replicons derived from positive strand RNA virus genomes useful for the production of heterologous proteins
04/24/2003US20030077250 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
04/24/2003US20030077249 DNA coding for one or more recombinant chimeric receptors comprising two or more different cytoplasmic signalling polypeptides; drug delivery system for treating cancer
04/24/2003US20030077246 TNFr/OPG-like molecules and uses thereof
04/24/2003DE19822287C2 Klonierungsvektor, seine Herstellung und Verwendung zur Analyse von mRNA Expressionsmuster Cloning vector, its preparation and use for the analysis of mRNA expression pattern
04/24/2003CA2775218A1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
04/24/2003CA2741049A1 Multiplexed analysis of polymorphic loci by probe elongation-mediated detection
04/24/2003CA2494706A1 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003CA2466889A1 Use of the adenoviral e2 late promoter
04/24/2003CA2463996A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications
04/24/2003CA2463979A1 Method of producing human beta cell lines
04/24/2003CA2463943A1 Human antibodies that have mn binding and cell adhesion-neutralizing activity
04/24/2003CA2463928A1 Starch
04/24/2003CA2463925A1 Bone anti-resorptive compounds
04/24/2003CA2463920A1 Methods for detecting ovarian cancer
04/24/2003CA2463916A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light
04/24/2003CA2463914A1 Conversion of liver stem and progenitor cells to pancreatic functional cells
04/24/2003CA2463816A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
04/24/2003CA2463672A1 Direct targeting binding proteins
04/24/2003CA2463641A1 Antisense antiviral agent and method for treating ssrna viral infection
04/24/2003CA2463634A1 Anti-hla-dr antibody
04/24/2003CA2463596A1 Method of screening cell death inhibitor
04/24/2003CA2463578A1 Differentially expressed genes associated with obesity and type 2 diabetes
04/24/2003CA2463492A1 Methods for the treatment of carcinoma
04/24/2003CA2463473A1 Targeted therapeutic proteins
04/24/2003CA2463317A1 Compositions and methods for using a solid support to purify rna
04/24/2003CA2463177A1 Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells
04/24/2003CA2463167A1 Production, detection and use of transformant cells
04/24/2003CA2463166A1 Production of oil with higher erucic acid content
04/24/2003CA2463040A1 Nucleic acid amplification methods
04/24/2003CA2463017A1 Method for preparation of single chain antibodies
04/24/2003CA2463003A1 Dimerized growth factor and materials and methods for producing it
04/24/2003CA2462942A1 Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same
04/24/2003CA2462785A1 Kinases and phosphatases
04/24/2003CA2462588A1 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
04/24/2003CA2461818A1 Treatment and diagnosis of insulin resistant states
04/24/2003CA2461245A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
04/24/2003CA2461171A1 High-throughput transcriptome and functional validation analysis
04/24/2003CA2457821A1 Coffee plant with reduced .alpha.-d-galactosidase activity
04/24/2003CA2455899A1 Compositions and methods for the modulation of viral maturation
04/24/2003CA2454578A1 Modified human thymic stromal lymphopoietin
04/23/2003EP1304388A2 Intergrated nucleic acid diagnostic device
04/23/2003EP1304386A1 Method of constructing self-assembly of probes and method of detecting the same
04/23/2003EP1304383A2 Sugarcane bacilliform virus promoter
04/23/2003EP1304382A2 Production of peptides in plants as viral coat protein fusions
04/23/2003EP1304381A2 Process for producing hydrophobic polypeptides, proteins or peptides
04/23/2003EP1304380A1 Human source gene leading sequence, gene vector and gene expression strategy
04/23/2003EP1304379A2 Humanised antibody against CD18
04/23/2003EP1304378A1 ARL-2 for fertility control
04/23/2003EP1304377A1 Method of detecting cancer
04/23/2003EP1304371A1 Cds1 GENE-KNOCKOUT CELLS AND MOUSE AND UTILIZATION THEREOF
04/23/2003EP1304336A2 Antibodies for specific detection of pathogenic prions of human origin and detection methods using them
04/23/2003EP1304335A2 Hepatitis C virus protease
04/23/2003EP1304119A2 Method for preventing and treating hearing loss using a neurturin protein product
04/23/2003EP1303760A2 Methods of identifying the activity of gene products
04/23/2003EP1303639A2 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
04/23/2003EP1303637A1 Method for isolating and characterizing nucleic acid sequences
04/23/2003EP1303628A1 Molecular control of transgene segregation and its escape by a recoverable block of function (rbf) system
04/23/2003EP1303627A1 Recombinant plasmid pdsbcm, microorganisms transformed therewith, and method for producing an alkaline protease vapk
04/23/2003EP1303626A1 Recombinant plasmid psp1, microorganisms transformed therewith, and method for producing an alkaline protease vapk
04/23/2003EP1303625A2 Alpha-msh related compounds and methods of use
04/23/2003EP1303624A2 Alanine racemase (alr) of corynebacterium glutamicum
04/23/2003EP1303623A2 Pheylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
04/23/2003EP1303622A1 Bioproduction of para-hydroxycinnamic acid
04/23/2003EP1303621A2 Novel cacao endoproteinases and their use in the production of cocoa flavour
04/23/2003EP1303620A2 Regulation of human desc1-like serine protease
04/23/2003EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction
04/23/2003EP1303618A2 Nucleic acid molecule which codes for a plant amp deaminase
04/23/2003EP1303617A2 Mutant muscle-specific enhancers
04/23/2003EP1303616A2 Nucleic acid sequences encoding beta-ketoacyl-acp synthase and uses thereof
04/23/2003EP1303615A2 Fermentation process for epothilones
04/23/2003EP1303614A2 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli
04/23/2003EP1303613A2 Rescue of canine distemper virus from cdna
04/23/2003EP1303612A2 Streptococcus antigens
04/23/2003EP1303611A2 Novel protein containing ring finger domaine r1p4
04/23/2003EP1303610A2 Extracellular matrix protein
04/23/2003EP1303609A2 G-protein coupled receptors
04/23/2003EP1303608A2 Zinc finger domain recognition code and uses thereof
04/23/2003EP1303607A2 High affinity soluble interleukin-18 receptor
04/23/2003EP1303606A2 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
04/23/2003EP1303605A2 Nucleic acids, vectors, host cells, polypeptides, and uses thereof
04/23/2003EP1303604A2 Mammalian receptor proteins; related reagents and methods
04/23/2003EP1303603A2 G protein-coupled receptor con-218
04/23/2003EP1303602A2 Soluble zalpha11 cytokine receptors
04/23/2003EP1303601A2 G protein-coupled receptors
04/23/2003EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
04/23/2003EP1303599A2 Methylated nucleotide regulation of upa gene expression
04/23/2003EP1303598A1 Molecular markers
04/23/2003EP1303597A2 Method of rna cleavage
04/23/2003EP1303596A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug
04/23/2003EP1303594A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b
04/23/2003EP1303593A2 Use of cyp52a2a promoter to increase gene expression in yeast
04/23/2003EP1303592A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same
04/23/2003EP1303591A2 Masp-2, a complement-fixing enzyme, and uses for it
04/23/2003EP1303590A1 Process for the fermentative preparation of l-threonine
1 ... 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 ... 4023